Cargando…

Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver

Simultaneous resection of synchronous hepatocellular carcinoma (HCC) and pancreatic ductal adenocarcinoma (PDAC) is extremely rare. Case 1 is a 64-year-old woman, who had undergone anterior resection for rectal cancer 3 years earlier was pointed out to have a cystic tumor in the pancreatic tail and...

Descripción completa

Detalles Bibliográficos
Autores principales: Taniai, Tomohiko, Haruki, Koichiro, Shiba, Hiroaki, Onda, Shinji, Sakamoto, Taro, Yanaga, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167653/
https://www.ncbi.nlm.nih.gov/pubmed/30283284
http://dx.doi.org/10.1159/000490658
_version_ 1783360242760810496
author Taniai, Tomohiko
Haruki, Koichiro
Shiba, Hiroaki
Onda, Shinji
Sakamoto, Taro
Yanaga, Katsuhiko
author_facet Taniai, Tomohiko
Haruki, Koichiro
Shiba, Hiroaki
Onda, Shinji
Sakamoto, Taro
Yanaga, Katsuhiko
author_sort Taniai, Tomohiko
collection PubMed
description Simultaneous resection of synchronous hepatocellular carcinoma (HCC) and pancreatic ductal adenocarcinoma (PDAC) is extremely rare. Case 1 is a 64-year-old woman, who had undergone anterior resection for rectal cancer 3 years earlier was pointed out to have a cystic tumor in the pancreatic tail and a solitary tumor in the liver. CT revealed a hypovascular tumor in the pancreatic tail and a liver tumor with early enhancement. With a diagnosis of simultaneous HCC and PDAC, she underwent laparotomy, in which intraoperative frozen section examination of the liver was compatible with HCC. Therefore, she underwent hepatic resection as well as distal pancreatectomy and splenectomy. The patient received adjuvant chemotherapy with S-1 and remains well with no evidence of tumor recurrence as of 28 months after resection. Case 2 is a 73-year-old man with sustained viral response to antiviral treatment for hepatitis C virus, who was pointed out to have a tumor in the pancreatic head and a solitary tumor in the liver. Gadoxetic acid-enhanced MRI exhibited enhancement compatible with HCC. With a diagnosis of concomitant HCC and PDAC, surgery was performed. Intraoperative frozen section examination was compatible with HCC, for which a pancreaticoduodenectomy was performed. The patient received adjuvant chemotherapy with S-1 and remains well with no evidence of tumor recurrence as of 16 months after resection. In conclusion, we describe 2 cases of hepato-pancreatectomy for synchronous double primary cancers of the pancreas and the liver, where exclusion of the liver tumor as a metastatic lesion from the pancreatic cancer is important.
format Online
Article
Text
id pubmed-6167653
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-61676532018-10-03 Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver Taniai, Tomohiko Haruki, Koichiro Shiba, Hiroaki Onda, Shinji Sakamoto, Taro Yanaga, Katsuhiko Case Rep Gastroenterol Case Series Simultaneous resection of synchronous hepatocellular carcinoma (HCC) and pancreatic ductal adenocarcinoma (PDAC) is extremely rare. Case 1 is a 64-year-old woman, who had undergone anterior resection for rectal cancer 3 years earlier was pointed out to have a cystic tumor in the pancreatic tail and a solitary tumor in the liver. CT revealed a hypovascular tumor in the pancreatic tail and a liver tumor with early enhancement. With a diagnosis of simultaneous HCC and PDAC, she underwent laparotomy, in which intraoperative frozen section examination of the liver was compatible with HCC. Therefore, she underwent hepatic resection as well as distal pancreatectomy and splenectomy. The patient received adjuvant chemotherapy with S-1 and remains well with no evidence of tumor recurrence as of 28 months after resection. Case 2 is a 73-year-old man with sustained viral response to antiviral treatment for hepatitis C virus, who was pointed out to have a tumor in the pancreatic head and a solitary tumor in the liver. Gadoxetic acid-enhanced MRI exhibited enhancement compatible with HCC. With a diagnosis of concomitant HCC and PDAC, surgery was performed. Intraoperative frozen section examination was compatible with HCC, for which a pancreaticoduodenectomy was performed. The patient received adjuvant chemotherapy with S-1 and remains well with no evidence of tumor recurrence as of 16 months after resection. In conclusion, we describe 2 cases of hepato-pancreatectomy for synchronous double primary cancers of the pancreas and the liver, where exclusion of the liver tumor as a metastatic lesion from the pancreatic cancer is important. S. Karger AG 2018-08-28 /pmc/articles/PMC6167653/ /pubmed/30283284 http://dx.doi.org/10.1159/000490658 Text en Copyright © 2018 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Series
Taniai, Tomohiko
Haruki, Koichiro
Shiba, Hiroaki
Onda, Shinji
Sakamoto, Taro
Yanaga, Katsuhiko
Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver
title Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver
title_full Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver
title_fullStr Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver
title_full_unstemmed Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver
title_short Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver
title_sort simultaneous resection for synchronous double primary cancers of the pancreas and the liver
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167653/
https://www.ncbi.nlm.nih.gov/pubmed/30283284
http://dx.doi.org/10.1159/000490658
work_keys_str_mv AT taniaitomohiko simultaneousresectionforsynchronousdoubleprimarycancersofthepancreasandtheliver
AT harukikoichiro simultaneousresectionforsynchronousdoubleprimarycancersofthepancreasandtheliver
AT shibahiroaki simultaneousresectionforsynchronousdoubleprimarycancersofthepancreasandtheliver
AT ondashinji simultaneousresectionforsynchronousdoubleprimarycancersofthepancreasandtheliver
AT sakamototaro simultaneousresectionforsynchronousdoubleprimarycancersofthepancreasandtheliver
AT yanagakatsuhiko simultaneousresectionforsynchronousdoubleprimarycancersofthepancreasandtheliver